Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the stock exchanges about the newspaper publication of its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results, as required under SEBI's Listing Regulations. The notice was published on July 31, 2025 in The Economic Times and The Free Press Journal (English dailies) and Maharashtra Times and Navshakti (regional dailies), along with a QR code and weblink to the full results. From the embedded standalone results: Total Income from Operations stood at ₹15,580.38 lakhs, Profit Before Tax at ₹2,515.36 lakhs, and Net Profit for the quarter at ₹1,942.01 lakhs, with basic EPS of ₹6.56. On a consolidated basis, Total Income from Operations was ₹18,776.54 lakhs and Net Profit was ₹1,665.26 lakhs. The full results are available on the BSE/NSE websites and the company's website.
This is a routine regulatory compliance filing confirming the results were published in newspapers as required — it does not contain new information beyond the Q1 results already disclosed. Investors should refer to the full Q1 results for a complete picture of the company's performance.